Cargando…

Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases

The main goal of this study is to consider SLC34A2 as a potential prognostic marker of oncological diseases using the mutational, expression, and survival data of cancer studies which are publicly available online. We collected data from four databases (cBioPortal, The Cancer Genome Atlas; cBioPorta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlasenkova, Ramilia, Nurgalieva, Alsina, Akberova, Natalia, Bogdanov, Mikhail, Kiyamova, Ramziya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699446/ https://www.ncbi.nlm.nih.gov/pubmed/34944522 http://dx.doi.org/10.3390/biom11121878

Ejemplares similares

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin
por: Skripova, Vera, et al.
Publicado: (2022)

Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells
por: Bulatova, Leisan, et al.
Publicado: (2022)

Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer
por: Nurgalieva, A.K., et al.
Publicado: (2021)

Cardiolipin is required in vivo for the stability of bacterial translocon and optimal membrane protein translocation and insertion
por: Ryabichko, Sergey, et al.
Publicado: (2020)

Phospholipid distribution in the cytoplasmic membrane of Gram-negative bacteria is highly asymmetric, dynamic, and cell shape-dependent
por: Bogdanov, Mikhail, et al.
Publicado: (2020)

Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas
por: Kostianets, Olga, et al.
Publicado: (2012)

Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades
por: Dyachenko, Lada, et al.
Publicado: (2016)

Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study
por: Hakim, Sarah Adel, et al.
Publicado: (2021)

Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations
por: Fearn, Amy, et al.
Publicado: (2018)

Overlapping Phenotypes Associated With CYP24A1, SLC34A1, and SLC34A3 Mutations: A Cohort Study of Patients With Hypersensitivity to Vitamin D
por: Molin, Arnaud, et al.
Publicado: (2021)

SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
por: Peng, Xiaozhen, et al.
Publicado: (2021)

Characterization of novel markers of senescence and their prognostic potential in cancer
por: Althubiti, M, et al.
Publicado: (2014)

The role of SLC34A2 in intestinal phosphate absorption and phosphate homeostasis
por: Marks, Joanne
Publicado: (2018)

Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion
por: Li, Yanhua, et al.
Publicado: (2016)

A novel SLC34A2 mutation in a patient with pulmonary alveolar microlithiasis
por: Izumi, Hiroki, et al.
Publicado: (2017)

Quantitative assessment of miR34a as an independent prognostic marker in breast cancer
por: Agarwal, Seema, et al.
Publicado: (2015)

Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays
por: Zhang, Fan, et al.
Publicado: (2021)

Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells
por: YANG, WEIHAN, et al.
Publicado: (2014)

Distinct functional properties of two electrogenic isoforms of the SLC34 Na‐Pi cotransporter
por: Mizutani, Natsuki, et al.
Publicado: (2019)

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

SLC34A3 Intronic Deletion in an Iranian Kindred with Hereditary Hypophosphatemic Rickets with Hypercalciuria
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2018)

Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis
por: Jönsson, Åsa Lina M., et al.
Publicado: (2022)

Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations
por: Boichuk, Sergei, et al.
Publicado: (2023)

Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma
por: Nicolas, Emmanuelle, et al.
Publicado: (2019)

SLC34A3 Intronic Deletion in a New Kindred with Hereditary Hypophosphatemic Rickets with Hypercalciuria
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2012)

Phosphate matters when investigating hypercalcemia: a mutation in SLC34A3 causing HHRH
por: Tang, Andrew R, et al.
Publicado: (2019)

SLC34A2 Up-regulation And SLC4A4 Down-regulation Correlates With Invasion, Metastasis, And The MAPK Signaling Pathway In Papillary Thyroid Carcinomas
por: Huang, Fengyan, et al.
Publicado: (2021)

Constitutive depletion of Slc34a2/NaPi-IIb in rats causes perinatal mortality
por: Pastor-Arroyo, Eva Maria, et al.
Publicado: (2021)

Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma
por: He, Jianxia, et al.
Publicado: (2021)

Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
por: Bodryagina, Evgenia, et al.
Publicado: (2022)

The use of the SLC16A1 gene as a potential marker to predict race performance in Arabian horses
por: Ropka-Molik, Katarzyna, et al.
Publicado: (2019)

Novel SLC34A3 mutation causing hereditary hypophosphataemic rickets with hypercalciuria in a Gambian family()
por: Braithwaite, Vickie, et al.
Publicado: (2013)

MON-255 A Novel Variant of SLC34A1 Gene in an Infant with Idiopathic Infantile Hypercalcemia
por: Moon, Jungeun, et al.
Publicado: (2019)

Heterozygous mutation of SLC34A1 in patients with hypophosphatemic kidney stones and osteoporosis: a case report
por: Ma, Yuping, et al.
Publicado: (2020)

Interdependent Transcription of a Natural Sense/Antisense Transcripts Pair (SLC34A1/PFN3)
por: Zinad, Hany S., et al.
Publicado: (2022)

Comprehensive analysis of pan-cancer reveals the potential of SLC16A1 as a prognostic and immunological biomarker
por: Chen, Lingyun, et al.
Publicado: (2023)

The effects and mechanisms of SLC34A2 in tumorigenesis and progression of human non-small cell lung cancer
por: Wang, Yu, et al.
Publicado: (2015)

Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: Novel Mutations in PHEX and SLC34A3
por: Acar, Sezer, et al.
Publicado: (2018)

Effect of SLC34A2 gene mutation on extracellular phosphorus transport in PAM alveolar epithelial cells
por: Ma, Tiangang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0s449g8qpc9iinfcdtlkk69d2i